Last updated on November 2017

Fibromyalgia Study

Brief description of study

Fibromyalgia Study

Detailed Study Description

A Phase 2 Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study For Patient With Moderate To Severe Fibromyalgia.

Inclusion Criteria

  • Subjects must be 18 to 59 years of age, inclusive, at the time of consent.
  • Subject must be willing and able to comply with all the testing and requirements defined in this protocol, as well as the restrictions and directions of the investigational site staff.
  • All male subjects must agree to use a highly effective method of birth control with partners of childbearing potential during the study and for 1 month after study dosing.

Exclusion Criteria:

  • Subjects with evidence of alcohol abuse within the past 12 months
  • Subjects who have a history of seizures (other than febrile seizures occurring before the age of 6 years)during the study and for 1 month after study dosing.

Clinical Study Identifier: TX7127

Contact Investigators or Research Sites near you

Start Over

Claudia Diaz

Northern California Research
Sacramento, CA USA